A detailed history of Ieq Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 68,637 shares of VTRS stock, worth $859,335. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,637
Previous 80,009 14.21%
Holding current value
$859,335
Previous $850,000 6.35%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $117,359 - $137,942
-11,372 Reduced 14.21%
68,637 $796,000
Q2 2024

Aug 12, 2024

BUY
$10.05 - $12.02 $385,970 - $461,628
38,405 Added 92.31%
80,009 $850,000
Q1 2024

May 08, 2024

BUY
$11.27 - $13.53 $57,634 - $69,192
5,114 Added 14.01%
41,604 $496,000
Q4 2023

Feb 07, 2024

SELL
$8.77 - $10.85 $50,278 - $62,203
-5,733 Reduced 13.58%
36,490 $395,000
Q3 2023

Nov 03, 2023

BUY
$9.59 - $11.35 $71,176 - $84,239
7,422 Added 21.33%
42,223 $416,000
Q2 2023

Aug 07, 2023

SELL
$9.02 - $10.29 $129,058 - $147,229
-14,308 Reduced 29.14%
34,801 $347,000
Q1 2023

May 01, 2023

BUY
$9.2 - $12.26 $206,558 - $275,261
22,452 Added 84.23%
49,109 $472,000
Q4 2022

Feb 03, 2023

SELL
$8.72 - $11.56 $113,124 - $149,967
-12,973 Reduced 32.74%
26,657 $296,000
Q3 2022

Nov 03, 2022

BUY
$8.48 - $11.13 $226,195 - $296,881
26,674 Added 205.88%
39,630 $338,000
Q2 2022

Jul 27, 2022

SELL
$9.95 - $12.27 $20,039 - $24,711
-2,014 Reduced 13.45%
12,956 $136,000
Q1 2022

Apr 26, 2022

BUY
$9.81 - $15.4 $146,855 - $230,538
14,970 New
14,970 $163,000
Q4 2021

Jan 31, 2022

SELL
$12.09 - $14.68 $249,718 - $303,215
-20,655 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$13.25 - $15.13 $115,460 - $131,842
8,714 Added 72.98%
20,655 $279,000
Q2 2021

Jul 29, 2021

BUY
$12.97 - $16.15 $154,874 - $192,847
11,941 New
11,941 $171,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.